Evidence map›Paper›PMID 31339797›Full record

Trial reportThe American journal of drug and alcohol abuse2020

Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial.

Elias Dakwar, Amy Mahony, C Jean Choi, Martina Pavlicova, Daniel Brooks, John P Mariani, Frances R Levin

Open access · greenAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The American journal of drug and alcohol abuse, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.Current topics in behavioral neurosciences · 2026
    Review
  2. Article
  3. Clinical management of cannabis withdrawal.Addiction (Abingdon, England) · 2022
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Elias DakwarDivision on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USA.
Amy MahonyDivision on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USA.
C Jean ChoiNew York State Psychiatric Institute, Biostatistics, New York, USA.
Martina PavlicovaMailman School of Public Health, Biostatistics, Columbia University, New York, NY, USA.
Daniel BrooksDivision on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USA.
John P MarianiDivision on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USA.
Frances R LevinDivision on Substance use Disorders, New York State Psychiatric Institute (NYSPI), Columbia University, New York, NY, USA.
New York Psychoanalytic Society and Institute · USColumbia University · USNew York State Psychiatric Institute

Funding

Substance Abuse Treatment Development and Clinical Research MentoringK24DA029647 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEVIN, FRANCES RUDNICK · 2010 to 2019
$1.8M
NIDA NIH HHS K24 DA029647
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenergic alpha-2 Receptor AgonistsAdultDelayed-Action PreparationsFeasibility StudiesFemaleGuanfacineHumansMaleMarijuana AbuseMiddle AgedPilot ProjectsUnited StatesAdrenergic alpha-2 Receptor AgonistsDelayed-Action PreparationsGuanfacineCannabis use disorderguanfacine

Identifiers

PMID31339797
PMCPMC6949416
OpenAlexW2963418518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.